Hys Ngan

29.9k total citations · 8 hit papers
521 papers, 21.5k citations indexed

About

Hys Ngan is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Hys Ngan has authored 521 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Molecular Biology, 113 papers in Epidemiology and 111 papers in Surgery. Recurrent topics in Hys Ngan's work include Cervical Cancer and HPV Research (95 papers), Gestational Trophoblastic Disease Studies (84 papers) and Ovarian cancer diagnosis and treatment (81 papers). Hys Ngan is often cited by papers focused on Cervical Cancer and HPV Research (95 papers), Gestational Trophoblastic Disease Studies (84 papers) and Ovarian cancer diagnosis and treatment (81 papers). Hys Ngan collaborates with scholars based in Hong Kong, China and United States. Hys Ngan's co-authors include Any Cheung, Patrick Maisonneuve, Franco Odicino, U. Beller, Karen K. L. Chan, David W. Chan, Ronnie Tung‐Ping Poon, John Wong, L.C. Wong and Wai‐Kuen Tso and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Hys Ngan

510 papers receiving 21.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

2002 2.0k citations Hys Ngan et al. profile →
Carcinoma of the Ovary

2006 971 citations Franco Odicino, Patrick Maisonneuve et al. International Journal of Gynecology & Obstetrics profile →
Carcinoma of the Corpus Uteri

2006 767 citations Franco Odicino, Patrick Maisonneuve et al. International Journal of Gynecology & Obstetrics profile →
Carcinoma of the Cervix Uteri

2006 456 citations Franco Odicino, Patrick Maisonneuve et al. International Journal of Gynecology & Obstetrics profile →
Update on the diagnosis and management of gestational trophoblastic disease

2018 259 citations Hys Ngan, Michael J. Seckl et al. International Journal of Gynecology & Obstetrics profile →
SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells

2022 153 citations Hys Ngan, Karen K. L. Chan et al. profile →
Molecular Biomarkers for the Early Detection of Ovarian Cancer

2022 130 citations Michelle K.Y. Siu, Hys Ngan et al. profile →
Diagnosis and management of gestational trophoblastic disease: 2021 update

2021 125 citations Hys Ngan, Michael J. Seckl et al. International Journal of Gynecology & Obstetrics profile →

Peers

Countries citing papers authored by Hys Ngan

Since Specialization

Citations

This map shows the geographic impact of Hys Ngan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hys Ngan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hys Ngan more than expected).

Fields of papers citing papers by Hys Ngan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hys Ngan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hys Ngan. The network helps show where Hys Ngan may publish in the future.

Co-authorship network of co-authors of Hys Ngan

This figure shows the co-authorship network connecting the top 25 collaborators of Hys Ngan. A scholar is included among the top collaborators of Hys Ngan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hys Ngan. Hys Ngan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnosis and management of gestational trophoblastic disease: 2025 update 2025 ·International Journal of Gynecology & Obstetrics ·Hys Ngan, Michael J. Seckl, Ross S. Berkowitz, Yang Xiang, François Golfier, Paradan K. Sekharan, Antônio L. Braga, Andrea Garrett	2
2	GTN Diagnosis and Staging 2024 ·Hematology/Oncology Clinics of North America ·Siew‐Fei Ngu, Hys Ngan	1
3	Building a baby‐friendly community: Development, strategy, implementation and evaluation of a BFCI program 2024 ·Journal of Advanced Nursing ·Kris Yuet Wan Lok, (unknown), (unknown), (unknown), (unknown), Janet Yuen Ha Wong, Edmond Pui Hang Choi, (unknown), Marie Tarrant, Hys Ngan, Patrick Ip, (unknown)	1
4	Acceptability of self-collected vaginal samples for human papillomavirus testing for primary cervical cancer screening: comparison of face-to-face and online recruitment modes 2024 ·BMC Public Health ·Siew‐Fei Ngu, (unknown), (unknown), Hys Ngan, Any Cheung, (unknown)	2
5	A Mobile App for Promoting Breastfeeding-Friendly Communities in Hong Kong: Design and Development Study 2024 ·JMIR Formative Research ·(unknown), (unknown), (unknown), Janet Yuen Ha Wong, Edmond Pui Hang Choi, (unknown), Marie Tarrant, Hys Ngan, Patrick Ip, Chia‐Chin Lin, Kris Yuet Wan Lok	0
6	Patient-Initiated Follow-Up in Ovarian Cancer 2023 ·Current Oncology ·(unknown), Siew‐Fei Ngu, (unknown), Ka Yu Tse, Mandy Man Yee Chu, (unknown), Hys Ngan, Karen K. L. Chan	3
7	Evaluation of an Isothermal Amplification HPV Assay on Self-Collected Vaginal Samples as Compared to Clinician-Collected Cervical Samples 2023 ·Diagnostics ·(unknown), Siew‐Fei Ngu, (unknown), (unknown), Hys Ngan, Any Cheung, Karen K. L. Chan	5
8	A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study 2023 ·Journal of Gynecologic Oncology ·Ting Deng, Kaijiang Liu, Liang Chen, Xiaojun Chen, (unknown), Hongyan Guo, (unknown), Libing Xiang, (unknown), (unknown), Hys Ngan, (unknown), Dongling Zou, Qing Liu, (unknown)	10
9	Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers 2020 ·Journal of Ovarian Research ·(unknown), K.W. Chiu, Mandy Man Yee Chu, Hys Ngan, Elaine Lee	6
10	Functional tumour burden of peritoneal carcinomatosis derived from DWI could predict incomplete tumour debulking in advanced ovarian carcinoma 2020 ·European Radiology ·Elaine Lee, (unknown), (unknown), K.W. Chiu, Edward S. Hui, Mandy Man Yee Chu, Hys Ngan	13
11	An Interactive Web-Based Sexual Health Literacy Program for Safe Sex Practice for Female Chinese University Students: Multicenter Randomized Controlled Trial 2020 ·Journal of Medical Internet Research ·Janet Yuen Ha Wong, Wen Zhang, Yongda Wu, Edmond Pui Hang Choi, Herman Hay Ming Lo, Wendy Wong, (unknown), Hau-lin Tam, Fei‐Wan Ngai, Marie Tarrant, Man Ping Wang, Hys Ngan, Dyt Fong	19
12	Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades 2019 ·Cancers ·Michelle K.Y. Siu, Yuxin Jiang, Jingjing Wang, Thomas Leung, Chae Young Han, Benjamin K. Tsang, Any Cheung, Hys Ngan, Karen K. L. Chan	103
13	Role Of Lymphadenectomy And Vincristine, Actinomycin-D, and Cyclophosphamide Chemotherapy in Malignant Ovarian Germ Cell Tumors 2018 ·European Journal of Gynaecological Oncology ·Siew‐Fei Ngu, (unknown), (unknown), (unknown), Philip P.C. Ip, Any Cheung, Hys Ngan	1
14	Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial 2012 ·The HKU Scholars Hub (University of Hong Kong) ·(unknown), (unknown), (unknown), (unknown), Alison H. Brand, (unknown), Thomas W. Jobling, (unknown), (unknown), (unknown), (unknown), (unknown), Martin K. Oehler, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hys Ngan, (unknown), (unknown), (unknown), (unknown), Karen K. L. Chan, C. David Wrede, (unknown), (unknown), (unknown), (unknown), (unknown), Anthony J. McCartney, (unknown)	26
15	iASPP and Chemoresistance in Ovarian Cancers: Effects on Paclitaxel-Mediated Mitotic Catastrophe 2011 ·Clinical Cancer Research ·(unknown), Michelle K.Y. Siu, Oscar Gee‐Wan Wong, (unknown), Xin Lü, Eric W.‐F. Lam, Hys Ngan, Xiao-Feng Le, Esther S.Y. Wong, Lara J. Monteiro, (unknown), Any Cheung	63
16	p70 S6 Kinase Promotes Epithelial to Mesenchymal Transition through Snail Induction in Ovarian Cancer Cells 2008 ·Cancer Research ·Yuen L. Pon, Hong Zhou, Any Cheung, Hys Ngan, Alice S.T. Wong	97
17	Transforming Growth Factor β1 Promotes Chromosomal Instability in Human Papillomavirus 16 E6E7–Infected Cervical Epithelial Cells 2008 ·Cancer Research ·Wen Deng, Sai Wah Tsao, Yvonne K. Kwok, (unknown), Xiao Ru Huang, Si Liu, Chi Man Tsang, Hys Ngan, Any Cheung, Hui Y. Lan, Xin‐Yuan Guan, Annie L.M. Cheung	33
18	Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility 2006 ·Carcinogenesis ·(unknown), Kelvin Y.K. Chan, Hys Ngan, US Khoo, Pei-Chen Chiu, Queeny K.Y. Chan, Weizhi Xue, Any Cheung	39
19	Mitomycin C and Cisplatin Enhanced the Antitumor Activity of p53-Expressing Adenovirus in Cervical Cancer Cells 2001 ·Cancer Investigation ·Tiangui Huang, (unknown), William S.B. Yeung, Hys Ngan	6
20	Carcinoma of the vulva. 2001 ·PubMed ·U. Beller, Mario Sideri, Patrick Maisonneuve, J.L. Benedet, A. Peter M. Heintz, Hys Ngan, Sërgio Pecorelli, Franco Odicino, William T. Creasman	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact